Thymmune is a biotechnology company developing a machine learning-driven thymic cell engineering platform to restore normal immune function in aging and disease. The company's cutting-edge approach in iPSC-thymic cell manufacturing can generate off-the-shelf cells at scale. The company is developing a pipeline of therapies to treat immunodeficiencies, transplant related, and autoimmune diseases. Thymmune is based in Cambridge, MA. For more information, visit www.thymmune.com.
Company Details
- Employees
- 28
- Address
- 238 Main St, Cambridge,massachusetts 02142,united States
- Industry
- Biotechnology
- Website
- https://www.thymmune.com/
- HQ
- Cambridge, Massachusetts
Thymmune Therapeutics Questions
Thymmune Therapeutics's website is https://www.thymmune.com/
Thymmune Therapeutics's LinkedIn profile is https://www.linkedin.com/company/thymmune
Thymmune Therapeutics has
28 employees.
View email and phone details for 28
employees at Thymmune Therapeutics.
Thymmune Therapeutics's industry is
Biotechnology
Thymmune Therapeutics's top competitors are
Kano Therapeutics,
Bazooka Tango,
Manifold,
Foundation Health,
Ciba Health,
Tava Health,
Cellino,
Ernest,
Aniai,
Derivita.
Thymmune Therapeutics's categories are Biotechnology
